Clinical Trials in the Category "Glioma"
Drug Intervention Trials that are Recruiting
Study Title |
Principal Investigator | Disease Category | |
 |
|||
| A Study of Pemetrexed in Children With Recurrent Cancer |
Dr. Neyssa Maria Marina |
Osteosarcoma
Neuroblastoma Medulloblastoma | |
|
|||
| Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma |
Dr. Neyssa Marina |
Central Nervous System Neoplasms
Brain Cancer Medulloblastoma | |
|
|||
| Low-Dose Radiation Therapy and Combination Chemotherapy Following Surgery in Treating Children With Newly Diagnosed Primitive Neuroectodermal Tumor or Medulloblastoma |
Paul Graham Fisher |
Central Nervous System Neoplasms
Brain Cancer Neuroectodermal Tumors Medulloblastoma | |
|
|||
Other Trials that are Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
| Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma |
Paul Graham Fisher |
Glioma | |
|
|||
Trials not Recruiting
| Study Title |
Principal Investigator | Disease Category | |
|
|||
|
Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia
(No longer recruiting) |
Dr. Neyssa Marina |
Leukemia
Lymphoma Neuroblastoma Medulloblastoma | |
|
|||
|
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
(No longer recruiting) |
Dr. Neyssa Marina |
Central Nervous System Neoplasms
Brain Cancer Glioma | |
|
|||
|
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
(No longer recruiting) |
Dr. Neyssa Marina |
Central Nervous System Neoplasms
Ependymoma Brain Cancer | |
|
|||
| The physicians of the Stanford Cancer Center are engaged in more than 250 clinical trials. Contracts with some of our clinical trial sponsors prevent us from listing specific trial information on our web site. Please contact the Stanford Cancer Clinical Trials Office at 650-498-7061 for information about additional open clinical trials. |
Trial Administration